Company Information

  

Address: 401 NORTH MICHIGAN AVENUE
SUITE 2700 
City: CHICAGO 
State: IL 
Zip Code: 60611 
Telephone: 312-324-7820 

Description of Business

Primary SIC Code: 8741
(As filed with the SEC)  

Accretive Health is a leading provider of revenue cycle services that help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician and staff satisfaction for our customers. We achieve these results for our customers through an integrated approach encompassing our end-to-end revenue cycle management service offering and physician advisory services. We do so by deploying a unique operating model that leverages our extensive healthcare site experience, innovative technology and process excellence. Our primary service offering consists of revenue cycle management, or RCM, which helps healthcare providers to more efficiently manage their revenue cycles. This encompasses patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation and collections from patients and third-party payers.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-0.28NAN/E
06/2017-0.03NAN/E
03/2017-0.32NAN/E
12/20160.65NA3.46
09/20160.68NA3.59

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity0.60Total Liab/Total Assets0.62
Net Inc/Total Assets0.43Total Liab/Inv Cap0.91
Net Inc/Inv Cap0.63Total Liab/Comm Equity0.87
Pretax Inc/Net Sales0.50Interest Coverage RatioNA
Net Inc/Net Sales0.30Curr Debt/EquityNA
Cash Flow/Net Sales-0.15LTD/EquityNA
SG&A/NetSales0.16Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover74.02Quick Ratio1.51
Inventory TurnoverNACurrent Ratio1.51
Inventory Day SalesNANet Rec/Curr Assets0.03
Net Sales/Work Cap8.53Inv/Curr AssetsNA
Net Sales/PP&E18.07  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) 123.20 99.40 86.90 106.16
Cost of Goods Sold 111.80 96.40 80.90 62.10
Selling & Admin Exps 16.50 13.20 14.50 16.56
Operating Income -5.10 -10.20 -8.50 27.50
Interest Exp NA NA NA NA
Pretax Income -5.10 -10.20 -8.40 27.60
Other Income 0.00 0.00 0.10 0.10
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -3.60 -6.70 -8.30 13.07

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 142.80 132.40 142.70 181.18
Receivables - Total 25.70 23.50 34.50 5.82
Inventories - Total NA NA NA NA
Total Current Assets 185.50 175.40 205.40 204.61
Net Property, Plant & Equipment 50.20 50.60 35.00 32.79
Total Assets 354.40 341.80 350.80 415.06
Liabilities        
Accounts Payable 52.20 47.50 46.70 51.22
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 73.20 59.40 62.50 135.11
Long-Term Debt NA NA NA NA
Total Liabilities 94.80 80.80 83.60 255.80
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 1.20 1.20 1.20 1.16
Retained Earnings -204.30 -200.70 -194.00 -304.70
Treasury Stock -59.60 -59.50 -57.80 -55.15
Total Stockholders' Equity 74.90 80.70 91.30 -12.33
Total Liabilities and Stockholders' Equity 169.70 161.50 174.90 243.47

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities 18.60 5.00 -27.90 -17.56
Net Cash Provided by Investing Activities -6.90 -14.00 -9.20 -2.21
Net Cash Provided by Financing Activities -1.30 -1.00 -2.10 -0.41

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201272.25-119.74--
12/2013504.77130.08--
12/2014210.14-79.62--
12/2015117.24-84.26--
12/2016592.56177.070.65
Growth Rates69.23----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/178649,82347.67




Report Date : 12/4/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.